Skip to content
Home/Companies/MedTech/Oncomedics
Oncomedics

Oncomedics

MedTech·France·Exited 2022·Held 6yr
Entry
2016
Hold
6yr
Exit
2022

Who owns Oncomedics?

Oncomedics is a French MedTech company, now owned by CliniSciences Group, which acquired it in 2022 from Aquiti Gestion.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Aquiti Gestion
Investor
Aquiti Gestion
NACI 1 · 2018 · Growth

Key facts

HQFrance
SectorMedTech
Websitewww.oncomedics.com
Exit Type
Trade Sale
Buyer
CliniSciences Group
Exit Year
2022

More from NACI 1

Other portfolio companies in the same fund.

Coravia
Active
France
EMAC
Active
IndustrialsFrance· 2025
Activ Inside
Activ Inside
Active
HealthcareFrance· 2024
Biscabois
Biscabois
Active
ConstructionFrance· 2022
Amedia Solutions
Active
TelecomFrance· 2021
HARMONY
Harmony
Active
ConsumerFrance· 2021

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Oncomedics?

Oncomedics is now owned by CliniSciences Group, which acquired it in 2022 from Aquiti Gestion.

When did CliniSciences Group acquire Oncomedics?

CliniSciences Group acquired Oncomedics in 2022, buying from Aquiti Gestion.

Who did Oncomedics sell to?

Aquiti Gestion sold Oncomedics to CliniSciences Group in 2022 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue